Justus Baron

Dr. Justus Baron is a Senior Research Associate in Economics at Northwestern University, Pritzker School of Law. Dr. Baron’s research focuses on technological innovation, standardization, and Intellectual Property Rights (IPR). Dr. Baron has written scholarly articles published in leading outlets, such as Research Policy, Antitrust Law Journal, and the International Journal of Industrial Organization, as well as several comprehensive policy reports for the European Commission. Dr. Baron has created the Searle Center Database, a collection of datasets on technology standards and SEPs used by numerous scholars in various fields.

Dr. Baron was a member of the European Commission’s Expert Group on Standard Essential Patents (SEP), and currently is the lead researcher of a consortium assisting the European Commission with an Impact Assessment on SEPs. Dr. Baron also frequently writes on standardization policy and the governance of standards organizations. Dr. Baron was one of the authors of a comprehensive EU report on SDO governance and SDO decision-making on IPR, has briefed the President’s National Security Telecommunications Advisory Committee Standards Subcommittee on the importance and measurement of leadership in standardization, and currently participates in a research project of the CERRE think tank on the EU’s Standardization Strategy.

(Transcript) Protecting Intellectual Property for National Security: A Conversation with Rep. Nathaniel Moran (R-TX)

This transcript is from a CSIS and LeadershIP event hosted on December 3, 2024. Watch the full video here. John J. Hamre: Good afternoon, everybody. Welcome. We’re delighted to have you here. My name is John Hamre. I’m the president at CSIS. And this is going to be one
Read More

Generic Drugs, Property Rights, and the Orange Book

By Chris Borges Intellectual property (IP) rights secured through patents facilitate the introduction of dozens of new brand-name drugs and hundreds of generic drugs annually in the United States. However, proposals advanced by the Biden administration have mistakenly singled out patents as the cause of high drug prices, potentially harming the dense networks
Read More

Intellectual Property Rights and the Future of U.S. Technological Leadership

By Dr. Kirti Gupta This commentary is part of a report from the CSIS Economic Security and Technology Department, titled Staying Ahead in the Global Technology Race. The report features a set of essays outlining key issues on economic security for the next administration, including global technology competition, industrialization
Read More